Wednesday, September 4, 2013

Novartis receives EU approval for Ilaris® in active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis

Novartis receives EU approval for Ilaris® in active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis

No comments:

Post a Comment